Wuzi AppTec announces renewal of partnership with BaseLaunch!
In an effort to further grow the flow of innovation centered in the Basel Area, WuXi AppTec and BaseLaunch have renewed their partnership to join forces to help young biopharmaceutical enterprises overcome some of the toughest hurdles in bringing novel therapeutics to market.
As a Domain Partner, WuXi AppTec supports up-and-coming enterprises in the BaseLaunch portfolio in the discovery and development of future therapeutics. With peer-recognized scientific leadership and expertise in oncology, immunology, infectious diseases, neurosciences, fibrosis, cardiovascular and metabolic diseases, WuXi AppTec works collaboratively to rapidly advance programs from initial discovery through to preclinical development and beyond.
“Now more than ever, we have the opportunity to better meet the individual needs of patients with knowledge, expertise, and collaboration,” says Dave Madge, Vice President of WuXi AppTec Discovery Services. “This partnership is an important step to further enable healthcare innovation and realize our vision that ‘every drug can be made and every disease can be treated.’”
